# Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

> **NCT02295059** · NA · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** omega 3 fatty acids

## Key facts

- **NCT ID:** NCT02295059
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-08-09
- **Primary completion:** 2027-02-05
- **Final completion:** 2027-02-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02295059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02295059, "Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02295059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*